Bio Pharma Dive
MAY 12, 2022
Deucravacitnib, forecast by Bristol Myers to hit $4 billion in peak sales, is under FDA review with an approval decision due by September. The agency's view of its safety will be key to its future.
XTalks
MAY 12, 2022
GoodPop is expanding its line of better-for-you frozen desserts with the introduction of Fudge n’ Vanilla Squares, which the company claims are the first plant-based and gluten-free frozen dessert squares. The Austin, Texas-based brand combined creamy vanilla oat milk ice cream with a chocolate fudge shell for its latest “cleaned up classics” product.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
MAY 12, 2022
The pharma will pay $90 million to license BridgeBio's experimental candidate, joining a lengthening list of large drugmakers aiming to treat cancer by blocking a protein called SHP2.
Pharma Times
MAY 12, 2022
High street service has been launched to support those experiencing symptoms potentially connected to the menopause
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Bio Pharma Dive
MAY 12, 2022
The deal hands $275 million upfront to Cullinan, whose medicine is being developed for a genetic driver of lung tumors that's become a top target for drugmakers.
Scienmag
MAY 12, 2022
GAINESVILLE, FLA. — Scientists have grown plants in soil from the Moon, a first in human history and a milestone in lunar and space exploration. Credit: UF/IFAS photo by Tyler Jones GAINESVILLE, FLA. — Scientists have grown plants in soil from the Moon, a first in human history and a milestone in lunar and space […].
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Scienmag
MAY 12, 2022
Switching to low carbon fuels for transportation, cooking, heating, power generation and other needs would help fight climate change and also reduce racial and ethnic disparities in exposure to air pollution, according to researchers at the University of California, Davis. Credit: Gregory Urquiaga/UC Davis Switching to low carbon fuels for transportation, cooking, heating, power generation […].
Pharma Times
MAY 12, 2022
The study is the UK’s most comprehensive allergy test, analysing 295 allergens, including well known potential food allergens
Scienmag
MAY 12, 2022
Have you ever been trapped in an unexpected torrential downpour? Weather forecasting systems have always tried to anticipate adverse weather events. These systems, however, are heavily dependent on bulky, stationary, expensive equipment such as weather radar, impeding timely updates on local weather conditions for personal use. Tackling this gap in knowledge and practicality, a research […].
Outsourcing Pharma
MAY 12, 2022
The two companies are forming a European Medical Advisory Committee to better connect patients and physicians, inviting other trial professionals to join in.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Scienmag
MAY 12, 2022
Regeneration of the central nervous system, including the brain and spinal cord, has been the central focus of Prof. Becker’s career. Already as a young doctoral student she was fascinated by the ability of fish, frogs, and salamanders to repair their central nervous systems and recover lost function – an extraordinary ability that humans do […].
pharmaphorum
MAY 12, 2022
AbbVie’s Allergan subsidiary and Teva are reportedly considering making a $5 billion-plus offer to try to bring opioid liability lawsuits to a conclusion. According to a Bloomberg report , the two drugmakers are facing more than 3,500 lawsuits related to their role in fuelling the opioid crisis in the US, and have been in talks over a possible settlement for more than a year.
Scienmag
MAY 12, 2022
BIRMINGHAM, Ala. – Lei Zhang, Ph.D., and Michael Niederweis, Ph.D., of the University of Alabama at Birmingham have made what they call “a major step” in understanding how Mycobacterium tuberculosis acquires iron from its human host — a process essential for the pathogenesis of this bacterium. Tuberculosis kills more than 1 million people each year, […].
pharmaphorum
MAY 12, 2022
AbbVie’s would-be blockbuster Rinvoq has notched up another positive trial in Crohn’s disease, showing that it can achieve clinical remission over a full year when used as a maintenance therapy. The results of the U-ENDURE study bolster the clinical case for Rinvoq (upadacitinib), which is trying to become the first drug in the JAK inhibitor class to be approved by the FDA for Crohn’s disease with a filing due this year.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Scienmag
MAY 12, 2022
Researchers have used a widespread species of blue-green algae to power a microprocessor continuously for a year – and counting – using nothing but ambient light and water. Their system has potential as a reliable and renewable way to power small devices. Credit: Paolo Bombelli Researchers have used a widespread species of blue-green algae to […].
BioPharma Reporter
MAY 12, 2022
These are some of the questions we will be asking leading experts next week.
Scienmag
MAY 12, 2022
The authors of a major study on the once critically endangered pink pigeon say boosting the species’ numbers is not enough to save it from extinction in the future. Credit: Mauritian Wildlife Foundation The authors of a major study on the once critically endangered pink pigeon say boosting the species’ numbers is not enough to […].
XTalks
MAY 12, 2022
Engineers at the University of California, San Diego (UCSD) developed a prototype of a wearable sensor for continuous monitoring of glucose, alcohol and lactate. High-tech step counters like Fitbit have increased in popularity as wearers can track their daily steps and calories burned with the watch-like device that uses accelerometers and altimeters to track how much they move throughout the day.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Scienmag
MAY 12, 2022
Despite the rapid melting of ice in many parts of Antarctica during the second half of the 20th century, researchers have found that the floating ice shelves which skirt the eastern Antarctic Peninsula have undergone sustained advance over the past 20 years. Credit: Frazer Christie Despite the rapid melting of ice in many parts of […].
BioPharma Reporter
MAY 12, 2022
Taiwan based CDMO, Bora Pharmaceuticals, says the acquisition of CDMO assets from local player, Eden Biologics, will help it build a presence in large-molecule contract drug development and manufacturing.
Scienmag
MAY 12, 2022
CHICAGO: Delays in surgery for esophageal cancer did not appear to have much impact on patients’ relative survival for early-stage cancer compared with patients who had surgery early, but they did reduce the relative survival rate by almost half for patients with more advanced disease, according to an analysis of the National Cancer Database (NCDB). […].
pharmaphorum
MAY 12, 2022
German drugmaker Boehringer Ingelheim has sold an artificial intelligence-powered software platform it developed to monitor drug safety data to ArisGlobal, which provides cloud software to life sciences companies. The platform – called BRASS (Benefit-Risk Analytic System) – was developed by Boehringer to unlock hidden patient safety signals from large data sets, and will be layered into ArisGlobal’s LifeSphere safety and pharmacovigilance platform.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Scienmag
MAY 12, 2022
Images in the wake of violent coastal storms usually focus purely on the extensive damage caused to beaches, dunes, property, and surrounding infrastructure. However, a new international study has shown that extreme weather events could help protect beaches from the impact of sea level rise – by bringing in new sand from deeper waters or […].
pharmaphorum
MAY 12, 2022
Bristol-Myers Squibb’s Celgene unit has clearly been impressed by progress in its four-year-old alliance with Evotec on protein degradation. It’s just paid $200 million to extend the partnership for eight more years and hiked its total value to a possible $5 billion. The two companies have been working on molecular glue degraders. These small drug compounds destabilise proteins by bringing them into proximity with enzymes called E3 ubiquitin ligases that cause them to be broken down.
Scienmag
MAY 12, 2022
The massive Jan. 15, 2022, eruption of the Hunga submarine volcano in the South Pacific Ocean created a variety of atmospheric wave types, including booms heard 6,200 miles away in Alaska. It also created an atmospheric pulse that caused an unusual tsunami-like disturbance that arrived at Pacific shores sooner than the actual tsunami. Those are […].
pharmaphorum
MAY 12, 2022
Johnson & Johnson has appointed Thibaut Mongon as the chief executive of its consumer health division, which is scheduled to be spun off into a listed company by the end of 2023. J&J announced its intention to separate consumer health from its faster-growing prescription medicine and medical device businesses last November, creating a separate company that will be home to well-recognised brands, including Band-Aid dressings, Johnson’s baby range, Listerine mouthwash, and Tylenol pa
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Scienmag
MAY 12, 2022
SAN FRANCISCO, CA—May 12, 2022—Viruses in the herpesvirus family are leading causes of birth defects, blindness, and failed organ transplants worldwide. Antiviral drugs can combat these viruses, but patients often develop resistance to the drugs—rendering them ineffective. Credit: Photo: Michael Short/Gladstone Institutes SAN FRANCISCO, CA—May 12, 2022—Viruses in the herpesvirus family are leading causes of […].
Outsourcing Pharma
MAY 12, 2022
Leaders from the biotech company share advice on how such organizations can make the most of often limited resources via smart strategy and collaboration.
Scienmag
MAY 12, 2022
ATLANTA, May 12, 2022 – New research led by scientists at the American Cancer Society (ACS) shows the need for continued surveillance of the changes in shopping interest and sales for Puff Bar, the most preferred brand of electronic cigarettes or e-cigarettes among youth in the United States. Public interest in shopping and sales of […].
NY Times
MAY 12, 2022
The limits of expanded access to experimental drugs.
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
275 
Let's personalize your content